Flavopiridol Mitigates the Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Targeting Cyclin-Dependent Kinase 9

PURPOSE: To investigate the role of cyclin-dependent kinase 9 (CDK9) and the therapeutic potential of a CDK9 inhibitor (flavopiridol) in monocrotaline (MCT)-induced pulmonary hypertension (PH). METHODS: For the in vivo experiments, rats with PH were established by a single intraperitoneal injection...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Qi, Hu, Zhiqiang, Song, Nannan, Mao, Weike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164032/
https://www.ncbi.nlm.nih.gov/pubmed/35088192
http://dx.doi.org/10.1007/s10557-021-07285-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164032/
https://www.ncbi.nlm.nih.gov/pubmed/35088192
http://dx.doi.org/10.1007/s10557-021-07285-w

Ejemplares similares